A recent pancreatic cancer OV screen showed that tumor-intrinsic antiviral defenses strongly influence efficacy: high interferon-stimulated gene expression correlated with resistance, whereas impaired IFN signaling (e.g., low cGAS/STING activity) enhanced sensitivity [135]. This evidence concerns the gene STING1 and familial pancreatic carcinoma.